Try our mobile app

General information

Country: UNITED STATES

Sector: Diagnostics and Research

Danaher Corporation designs, manufactures, and markets professional, medical, industrial and commercial products, and services in the sectors of test and measurement, environmental, life sciences, dental, and industrial technologies.
Website: danaher.com


  • Bad financial results growth rate -9.7% (average between last period year over year growth for revenue and EBITDA), there is slowdown compared to average historical growth rates (-3.9%)
  • Dividend yield for the last twelve months 0.5%
  • Free cash flow yield -0.7% (LTM)
  • Share price is 23.5% higher than minimum and 30.5% lower than maximum for the last 3 years
  • The company is overvalued by EV / LTM EBITDA multiple compared to target level (28.6x vs
    )
  • Fundamental value created in LTM (estimate)
  • For the last 3 months insiders sold company shares on $7.9 mln (-0.005% of cap.)

Key Financials (Download financials)

Ticker: DHR
Share price, USD:  (+1.1%)228.55
year average price 251.60  


year start price 230.36 2023-12-23

min close price 224.58 2024-01-17

max close price 280.76 2024-08-01

current price 228.55 2024-12-21
Common stocks: 727 076 992

Dividend Yield:  0.5%
FCF Yield LTM: -0.7%
EV / LTM EBITDA: 28.6x
EV / EBITDA annualized: 25.8x
Last revenue growth (y/y):  -19.8%
Last growth of EBITDA (y/y):  +0.3%
Historical revenue growth:  -1.3%
Historical growth of EBITDA:  -6.5%
Target EV / EBITDA (hist percentile):
Fundamental value created in LTM:
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 166 173
Net Debt ($m): 12 542
EV (Enterprise Value): 178 715
EBITDA LTM ($m): 6 246
EV / LTM EBITDA: 28.6x
Price to Book: 3.2x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / EBITDA

Potential dynamics

News


2024-12-17youtube.com

3 of the Best Companies to Own in 2025 and Beyond

2024-12-10prnewswire.com

Danaher Announces Quarterly Dividend

2024-12-10zacks.com

Here's Why You Should Avoid Investing in Danaher Stock Right Now

2024-12-10seekingalpha.com

Danaher: A Resilient And Solid Company With Growth Potential

2024-12-05seekingalpha.com

Danaher Corporation (DHR) Annual Evercore ISI HealthCONx Healthcare Conference (Transcript)

2024-11-26prnewswire.com

Danaher to Present at Evercore ISI HealthCONx Conference

2024-10-28zacks.com

Danaher (DHR) Reliance on International Sales: What Investors Need to Know

2024-10-22benzinga.com

Danaher's Q3 Earnings Boosted By Bioprocessing Order Growth, Analyst Maintain Stock Rating

2024-10-22zacks.com

Danaher Q3 Earnings Surpass Estimates, Diagnostics Sales Up Y/Y

2024-10-22zacks.com

Stock Markets Taper on High Valuations, Upcoming Election
More information for subscribed users:
detailed calculation of
Potential and Created Value,
website traffic data